Jinlan Shan

Elevated HMGA2 expression is associated with cancer aggressiveness and predicts poor outcome in breast cancer.

Jian Wang, Yun Yen, Xiaochen Wang, 2016, Cancer letters.

Ribonucleotide reductase M2 subunit silencing suppresses tumorigenesis in pancreatic cancer via inactivation of PI3K/AKT/mTOR pathway.

Xiyong Liu, Xiaochen Wang, Jinlan Shan, 2022, Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.].

Breast malignant phyllodes tumor with rare pelvic metastases and long-term overall survival

Ling Li, Shizhen Zhang, Jinlan Shan, 2016, Medicine.

Effect of postoperative radiotherapy in women with localized pure mucinous breast cancer after lumpectomy: a population-based study

Jinlan Shan, Xiaochen Wang, Qiuping Mo, 2021, Radiation oncology.

Association of genetic and immuno-characteristics with clinical outcomes in patients with RET-rearranged non-small cell lung cancer: a retrospective multicenter study

Yi-long Wu, Jin-Ji Yang, Jun Zhao, 2020, Journal of Hematology & Oncology.

Nuclear expression and/or reduced membranous expression of β-catenin correlate with poor prognosis in colorectal carcinoma

Siqi Guan, Daozhe Lin, Ling Li, 2016, Medicine.

Prognostic values of F-box members in breast cancer: an online database analysis and literature review

Shizhen Zhang, Jinlan Shan, Xiaochen Wang, 2018, Bioscience reports.

Role of high mobility group A1 and body mass index in the prognosis of patients with breast cancer

Jian Wang, Jingjing Wu, Shizhen Zhang, 2017, Oncology letters.

Clinical prognostic value of A FOXM1 related long non-coding RNA expression in gastric cancer.

Jinlan Shan, R. Wang, C.-S. Yang, 2018, European review for medical and pharmacological sciences.

Distinct prognostic values of S100 mRNA expression in breast cancer

Ling Li, Shizhen Zhang, Jinlan Shan, 2017, Scientific Reports.